2型糖尿病患者与对照者肠道胆汁酸受体和转运蛋白的表达
研究对12例2型糖尿病患者和12名健康对照者沿肠道取黏膜活检行mRNA测序,报告ASBT、OSTα/β、FXR、TGR5、FGF19和FGFR4的表达谱。2型糖尿病患者FGF19、FXR、ASBT和OSTα/β mRNA水平较低,但多重检验校正后差异无统计学意义。结论指出肠道胆汁酸转运蛋白和受体呈不同表达模式,2型糖尿病中ASBT、OSTα/β、FXR和FGF19 mRNA有降低迹象。
要点
- ASBT和OSTα/β在十二指肠可见表达,沿小肠升高,大肠中ASBT无表达、OSTα/β降低。
- FXR表达模式与OSTα/β一致,FGFR4沿肠道均匀表达,TGR5和FGF19水平极低。
- 2型糖尿病患者FGF19、FXR、ASBT和OSTα/β mRNA较低,但多重检验校正后无统计学意义。
核心结论
- 研究显示胆汁酸转运蛋白和受体沿肠道呈不同表达模式,2型糖尿病中ASBT、OSTα/β、FXR和FGF19 mRNA有降低迹象。
研究设计与样本
- 对12例2型糖尿病患者和12名健康对照者沿肠道取黏膜活检行mRNA测序,报告ASBT、OSTα/β、FXR、TGR5、FGF19和FGFR4的表达谱。
主要发现
- ASBT和OSTα/β在两组十二指肠均可见表达,沿小肠水平升高,大肠中ASBT无表达、OSTα/β水平降低。
- FXR表达模式与OSTα/β一致,FGFR4沿肠道均匀表达,TGR5和FGF19水平极低。
- 2型糖尿病患者FGF19、FXR、ASBT和OSTα/β mRNA水平低于健康对照,但多重检验校正后差异无统计学意义。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: The enterohepatic circulation of bile acids depends on intestinal absorption by bile acid transporters and activation of bile acid receptors, which stimulates secretion of hormones regulating glucose and lipid metabolism and appetite. Distribution of bile acid transporters and receptors in the human gut and their potential involvement in type 2 diabetes (T2D) pathophysiology remain unknown. OBJECTIVE: We explored the expression of genes involved in bile acid metabolism throughout the intestines of patients with T2D and matched healthy controls. METHODS: Intestinal mucosa biopsies sampled along the intestinal tract in 12 individuals with T2D and 12 healthy controls underwent messenger RNA (mRNA) sequencing. We report expression profiles of apical sodium-dependent bile acid transporter (ASBT), organic solute transporter (OST) α/β, farnesoid X receptor (FXR), Takeda G receptor 5 (TGR5), fibroblast growth factor 19 (FGF19), and FGF receptor 4 (FGFR4). RESULTS: Expression of ASBT and OSTα/β was evident in the duodenum of both groups with increasing levels through the small intestine, and no (ASBT) or decreasing levels (OSTα/β) through the large intestine. The FXR expression pattern followed that of OSTα/β whereas FGFR4 was evenly expressed through the intestines. Negligible levels of TGR5 and FGF19 were evident. Patients with T2D exhibited lower levels of FGF19, FXR, ASBT, and OSTα/β mRNAs compared with healthy controls, although the differences were not statistically significant after adjusting for multiple testing. CONCLUSION: We demonstrate distinct expression patterns of bile acid transporters and receptors through the intestinal tract with signs of reduced ASBT, OSTα/β, FXR, and FGF19 mRNAs in T2D.
引用
- Nerild HH, Gilliam-Vigh H, Ellegaard AM, et al. Expression of Bile Acid Receptors and Transporters Along the Intestine of Patients With Type 2 Diabetes and Controls. J Clin Endocrinol Metab. 2025. PMID: 38636096. doi:10.1210/clinem/dgae261
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。